Gender
Slow-Release Dihydropyridines Other Than Nifedipine Or Amlopidine (SHHS2) vs SHHS Visit Number
Visit 1 | Interim Follow-up Visit | Visit 2 | CVD Outcomes | |
---|---|---|---|---|
Total | - | - | 4,080 | - |
No | - | - | 3,563 | - |
Yes | - | - | 57 | - |
Don't know | - | - | - | - |
Unknown | - | - | 460 | - |
Slow-Release Dihydropyridines Other Than Nifedipine Or Amlopidine (SHHS2) vs Gender
Visit 2
Male | Female | Total | |
---|---|---|---|
Total | 1,861 | 2,219 | 4,080 |
No | 1,631 | 1,932 | 3,563 |
Yes | 30 | 27 | 57 |
Don't know | - | - | - |
Unknown | 200 | 260 | 460 |
Slow-Release Dihydropyridines Other Than Nifedipine Or Amlopidine (SHHS2) vs Race
Visit 2
White | Black | Other | Total | |
---|---|---|---|---|
Total | 3,587 | 256 | 237 | 4,080 |
No | 3,120 | 231 | 212 | 3,563 |
Yes | 42 | 11 | 4 | 57 |
Don't know | - | - | - | - |
Unknown | 425 | 14 | 21 | 460 |